Evidence mapPaperPMID 41599695Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Novel Angiotensin-Converting Enzyme Inhibitory Peptides from

Yingying Ren, Han He, Yubin Cai, Shuyan Han, Ayzohra Ablat, Qiang Yin, Dandan Mu

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yingying RenKey Laboratory of Xinjiang Phytomedicine Resource and Utilization, Pharmacy College of Shihezi University, Shihezi 832003, China.
Han HeState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.ORCID 0009-0007-6039-1735
Yubin CaiState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.ORCID 0009-0005-2902-7834
Shuyan HanState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.
Ayzohra AblatState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.
Qiang YinKey Laboratory of Xinjiang Phytomedicine Resource and Utilization, Pharmacy College of Shihezi University, Shihezi 832003, China.ORCID 0000-0002-2823-4664
Dandan MuState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.

Funding

the Xinjiang Uygur Autonomous Region Tianshan Yingcai Young Talent in Scientific and Tech-nological Innovation 2023TSYCCX0073
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACE inhibitory peptideBungarus multicinctusenzyme kineticsmolecular dockingsimulated gastrointestinal digestionstability analysis

Identifiers

PMID41599695
PMCPMC12844674

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.